In our case, a molecular genetic study of the primary tumor material revealed clinically significant somatic variants in the APC, TP53, and PTPN11 genes, which is a typical driver event in the initiation of malignant transformation in CRC [67,68]. This evidence concerns the gene TP53 and colorectal carcinoma.